Skip to main content
Clinical Trials/NL-OMON46384
NL-OMON46384
Completed
Phase 2

eo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility - NEOCON-F

Antoni van Leeuwenhoek Ziekenhuis0 sites120 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
cervical cancer
Sponsor
Antoni van Leeuwenhoek Ziekenhuis
Enrollment
120
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Antoni van Leeuwenhoek Ziekenhuis

Eligibility Criteria

Inclusion Criteria

  • \* Stage Ib1 cervical cancer measuring \*2 \- \*4 cm on physical examination and imaging in any direction
  • \* Histologic type: squamous cell carcinoma (SCC), adeno cell carcinoma (ACC), adeno\-squamous cell carcinoma (ASC)
  • \* Age \*18 years and \* 40 years
  • \* MRI abdomen and pelvis, chest X\-ray must be performed and negative for metastatic disease within 12 weeks of enrolment
  • \* No metastases on pelvic lymph node dissection

Exclusion Criteria

  • \* Involvement of tumor in uterine corpus on MRI or hysteroscopy if performed
  • \* Evidence of metastatic disease on imagining (PET/CT/MRI) performed within 12 weeks of enrolment
  • \* other diagnosis of malignancy or evidence of other malignancy for 5 years before screening for this study (except non\-melanoma skin cancer).

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
eo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertilitywomen =18 and = 40 years with FIGO stage Ib1 cervical carcinoma with tumor measuring = 2 cm and = 4 cm on physical examination and imagingMedDRA version: 20.0Level: HLTClassification code 10008230Term: Cervix neoplasms malignantSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2017-003102-40-NLKI-AV120
Completed
Phase 2
eo-adjuvant chemotherapy, cytoreductive surgery with hypethermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin.peritoneal cancerperitoneal carcinomatosis100346521001799110017998
NL-OMON38114niversitair Medisch Centrum Groningen50
Active, not recruiting
Not Applicable
Pre treatment with chemotherapy followed by surgery and removal of all intra-abdominal tumor and intra-peritoneal heated chemotherapy for peritoneal metastastasized colorectal cancer.
EUCTR2010-020787-37-NLniversitair Medisch Centrum Groningen10
Active, not recruiting
Phase 1
Chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastasesThe CHARISMA randomized multicenter clinical trial
EUCTR2013-004952-39-NLErasmus MC Cancer Institute224
Completed
Phase 3
eo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases ;The CHARISMA randomized multicenter clinical trialLiver metastases colorectal cancer1001981510017998
NL-OMON44796Erasmus MC, Universitair Medisch Centrum Rotterdam224